Global Irritable Bowel Syndrome Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 92 pages | ID: G76D16CBF97DEN
QYResearch

Abstracts

This report focuses on the global Irritable Bowel Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Irritable Bowel Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Bausch Health
• Sucampo Pharmaceuticals
• Abbott Laboratories
• Lexicon Pharmaceuticals
• Salix Pharmaceuticals
• Ironwood Pharmaceuticals
• GlaxoSmithKline
• Allergan

Market segment by Type, the product can be split into

• Irritable Bowel Syndrome with Constipation
• Irritable Bowel Syndrome with Diarrhea
• Irritable Bowel Syndrome with alternating Constipationand Diarrhea

Market segment by Application, split into

• Hospitals
• Clinics
• Homecare settings

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Irritable Bowel Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Irritable Bowel Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Irritable Bowel Syndrome Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Irritable Bowel Syndrome Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Irritable Bowel Syndrome with Constipation
  1.4.3 Irritable Bowel Syndrome with Diarrhea
  1.4.4 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
1.5 Market by Application
  1.5.1 Global Irritable Bowel Syndrome Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Homecare settings
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Irritable Bowel Syndrome Treatment Market Perspective (2015-2026)
2.2 Irritable Bowel Syndrome Treatment Growth Trends by Regions
  2.2.1 Irritable Bowel Syndrome Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Irritable Bowel Syndrome Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Irritable Bowel Syndrome Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Irritable Bowel Syndrome Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Irritable Bowel Syndrome Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Irritable Bowel Syndrome Treatment Players by Market Size
  3.1.1 Global Top Irritable Bowel Syndrome Treatment Players by Revenue (2015-2020)
  3.1.2 Global Irritable Bowel Syndrome Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Irritable Bowel Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio
  3.2.1 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Treatment Revenue in 2019
3.3 Irritable Bowel Syndrome Treatment Key Players Head office and Area Served
3.4 Key Players Irritable Bowel Syndrome Treatment Product Solution and Service
3.5 Date of Enter into Irritable Bowel Syndrome Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Irritable Bowel Syndrome Treatment Historic Market Size by Type (2015-2020)
4.2 Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Type (2021-2026)

5 IRRITABLE BOWEL SYNDROME TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020)
5.2 Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Irritable Bowel Syndrome Treatment Market Size (2015-2020)
6.2 Irritable Bowel Syndrome Treatment Key Players in North America (2019-2020)
6.3 North America Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020)
6.4 North America Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Irritable Bowel Syndrome Treatment Market Size (2015-2020)
7.2 Irritable Bowel Syndrome Treatment Key Players in Europe (2019-2020)
7.3 Europe Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020)
7.4 Europe Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Irritable Bowel Syndrome Treatment Market Size (2015-2020)
8.2 Irritable Bowel Syndrome Treatment Key Players in China (2019-2020)
8.3 China Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020)
8.4 China Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Irritable Bowel Syndrome Treatment Market Size (2015-2020)
9.2 Irritable Bowel Syndrome Treatment Key Players in Japan (2019-2020)
9.3 Japan Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020)
9.4 Japan Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Irritable Bowel Syndrome Treatment Market Size (2015-2020)
10.2 Irritable Bowel Syndrome Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Irritable Bowel Syndrome Treatment Market Size (2015-2020)
11.2 Irritable Bowel Syndrome Treatment Key Players in India (2019-2020)
11.3 India Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020)
11.4 India Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Irritable Bowel Syndrome Treatment Market Size (2015-2020)
12.2 Irritable Bowel Syndrome Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020)
12.4 Central & South America Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bausch Health
  13.1.1 Bausch Health Company Details
  13.1.2 Bausch Health Business Overview and Its Total Revenue
  13.1.3 Bausch Health Irritable Bowel Syndrome Treatment Introduction
  13.1.4 Bausch Health Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020))
  13.1.5 Bausch Health Recent Development
13.2 Sucampo Pharmaceuticals
  13.2.1 Sucampo Pharmaceuticals Company Details
  13.2.2 Sucampo Pharmaceuticals Business Overview and Its Total Revenue
  13.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
  13.2.4 Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020)
  13.2.5 Sucampo Pharmaceuticals Recent Development
13.3 Abbott Laboratories
  13.3.1 Abbott Laboratories Company Details
  13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.3.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Introduction
  13.3.4 Abbott Laboratories Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020)
  13.3.5 Abbott Laboratories Recent Development
13.4 Lexicon Pharmaceuticals
  13.4.1 Lexicon Pharmaceuticals Company Details
  13.4.2 Lexicon Pharmaceuticals Business Overview and Its Total Revenue
  13.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
  13.4.4 Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020)
  13.4.5 Lexicon Pharmaceuticals Recent Development
13.5 Salix Pharmaceuticals
  13.5.1 Salix Pharmaceuticals Company Details
  13.5.2 Salix Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
  13.5.4 Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020)
  13.5.5 Salix Pharmaceuticals Recent Development
13.6 Ironwood Pharmaceuticals
  13.6.1 Ironwood Pharmaceuticals Company Details
  13.6.2 Ironwood Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
  13.6.4 Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020)
  13.6.5 Ironwood Pharmaceuticals Recent Development
13.7 GlaxoSmithKline
  13.7.1 GlaxoSmithKline Company Details
  13.7.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.7.3 GlaxoSmithKline Irritable Bowel Syndrome Treatment Introduction
  13.7.4 GlaxoSmithKline Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020)
  13.7.5 GlaxoSmithKline Recent Development
13.8 Allergan
  13.8.1 Allergan Company Details
  13.8.2 Allergan Business Overview and Its Total Revenue
  13.8.3 Allergan Irritable Bowel Syndrome Treatment Introduction
  13.8.4 Allergan Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020)
  13.8.5 Allergan Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Irritable Bowel Syndrome Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Irritable Bowel Syndrome Treatment Revenue
Table 3. Ranking of Global Top Irritable Bowel Syndrome Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Irritable Bowel Syndrome with Constipation
Table 6. Key Players of Irritable Bowel Syndrome with Diarrhea
Table 7. Key Players of Irritable Bowel Syndrome with alternating Constipationand Diarrhea
Table 8. Global Irritable Bowel Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Irritable Bowel Syndrome Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Irritable Bowel Syndrome Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Irritable Bowel Syndrome Treatment Market Share by Regions (2015-2020)
Table 12. Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Irritable Bowel Syndrome Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Irritable Bowel Syndrome Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Irritable Bowel Syndrome Treatment Players
Table 19. Global Irritable Bowel Syndrome Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Irritable Bowel Syndrome Treatment Market Share by Players (2015-2020)
Table 21. Global Top Irritable Bowel Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome Treatment as of 2019)
Table 22. Global Irritable Bowel Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Irritable Bowel Syndrome Treatment Product Solution and Service
Table 25. Date of Enter into Irritable Bowel Syndrome Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Irritable Bowel Syndrome Treatment Market Size Share by Type (2015-2020)
Table 29. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Irritable Bowel Syndrome Treatment Market Size Share by Application (2015-2020)
Table 31. Global Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Irritable Bowel Syndrome Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Irritable Bowel Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Irritable Bowel Syndrome Treatment Market Share (2019-2020)
Table 35. North America Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Irritable Bowel Syndrome Treatment Market Share by Type (2015-2020)
Table 37. North America Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Irritable Bowel Syndrome Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Irritable Bowel Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Irritable Bowel Syndrome Treatment Market Share (2019-2020)
Table 41. Europe Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Irritable Bowel Syndrome Treatment Market Share by Type (2015-2020)
Table 43. Europe Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Irritable Bowel Syndrome Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Irritable Bowel Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Irritable Bowel Syndrome Treatment Market Share (2019-2020)
Table 47. China Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Irritable Bowel Syndrome Treatment Market Share by Type (2015-2020)
Table 49. China Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Irritable Bowel Syndrome Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Irritable Bowel Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Irritable Bowel Syndrome Treatment Market Share (2019-2020)
Table 53. Japan Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Irritable Bowel Syndrome Treatment Market Share by Type (2015-2020)
Table 55. Japan Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Irritable Bowel Syndrome Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Irritable Bowel Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Irritable Bowel Syndrome Treatment Market Share (2019-2020)
Table 59. Southeast Asia Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Irritable Bowel Syndrome Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Irritable Bowel Syndrome Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Irritable Bowel Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Irritable Bowel Syndrome Treatment Market Share (2019-2020)
Table 65. India Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Irritable Bowel Syndrome Treatment Market Share by Type (2015-2020)
Table 67. India Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Irritable Bowel Syndrome Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Irritable Bowel Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Irritable Bowel Syndrome Treatment Market Share (2019-2020)
Table 71. Central & South America Irritable Bowel Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Irritable Bowel Syndrome Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Irritable Bowel Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Irritable Bowel Syndrome Treatment Market Share by Application (2015-2020)
Table 75. Bausch Health Company Details
Table 76. Bausch Health Business Overview
Table 77. Bausch Health Product
Table 78. Bausch Health Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020) (Million US$)
Table 79. Bausch Health Recent Development
Table 80. Sucampo Pharmaceuticals Company Details
Table 81. Sucampo Pharmaceuticals Business Overview
Table 82. Sucampo Pharmaceuticals Product
Table 83. Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020) (Million US$)
Table 84. Sucampo Pharmaceuticals Recent Development
Table 85. Abbott Laboratories Company Details
Table 86. Abbott Laboratories Business Overview
Table 87. Abbott Laboratories Product
Table 88. Abbott Laboratories Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020) (Million US$)
Table 89. Abbott Laboratories Recent Development
Table 90. Lexicon Pharmaceuticals Company Details
Table 91. Lexicon Pharmaceuticals Business Overview
Table 92. Lexicon Pharmaceuticals Product
Table 93. Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020) (Million US$)
Table 94. Lexicon Pharmaceuticals Recent Development
Table 95. Salix Pharmaceuticals Company Details
Table 96. Salix Pharmaceuticals Business Overview
Table 97. Salix Pharmaceuticals Product
Table 98. Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020) (Million US$)
Table 99. Salix Pharmaceuticals Recent Development
Table 100. Ironwood Pharmaceuticals Company Details
Table 101. Ironwood Pharmaceuticals Business Overview
Table 102. Ironwood Pharmaceuticals Product
Table 103. Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020) (Million US$)
Table 104. Ironwood Pharmaceuticals Recent Development
Table 105. GlaxoSmithKline Company Details
Table 106. GlaxoSmithKline Business Overview
Table 107. GlaxoSmithKline Product
Table 108. GlaxoSmithKline Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020) (Million US$)
Table 109. GlaxoSmithKline Recent Development
Table 110. Allergan Business Overview
Table 111. Allergan Product
Table 112. Allergan Company Details
Table 113. Allergan Revenue in Irritable Bowel Syndrome Treatment Business (2015-2020) (Million US$)
Table 114. Allergan Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Irritable Bowel Syndrome Treatment Market Share by Type: 2020 VS 2026
Figure 2. Irritable Bowel Syndrome with Constipation Features
Figure 3. Irritable Bowel Syndrome with Diarrhea Features
Figure 4. Irritable Bowel Syndrome with alternating Constipationand Diarrhea Features
Figure 5. Global Irritable Bowel Syndrome Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Homecare settings Case Studies
Figure 9. Irritable Bowel Syndrome Treatment Report Years Considered
Figure 10. Global Irritable Bowel Syndrome Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Irritable Bowel Syndrome Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Irritable Bowel Syndrome Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Irritable Bowel Syndrome Treatment Market Share by Players in 2019
Figure 15. Global Top Irritable Bowel Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Treatment Revenue in 2019
Figure 17. North America Irritable Bowel Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Irritable Bowel Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Irritable Bowel Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Irritable Bowel Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Irritable Bowel Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Irritable Bowel Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Irritable Bowel Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2015-2020)
Figure 26. Sucampo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Sucampo Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2015-2020)
Figure 28. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Abbott Laboratories Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2015-2020)
Figure 30. Lexicon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Lexicon Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2015-2020)
Figure 32. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Salix Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2015-2020)
Figure 34. Ironwood Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Ironwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2015-2020)
Figure 36. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. GlaxoSmithKline Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2015-2020)
Figure 38. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Allergan Revenue Growth Rate in Irritable Bowel Syndrome Treatment Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed